TY  - GEN
AU  - Glutsch,V
AU  - Kneitz,H
AU  - Goebeler,M
AU  - Gesierich,A
AU  - Schilling,B
TI  - Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
SN  - 1569-8041
PY  - 2020///0731
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Merkel Cell
KW  - drug therapy
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - Humans
KW  - Ipilimumab
KW  - Male
KW  - Middle Aged
KW  - Nivolumab
KW  - Prognosis
KW  - Skin Neoplasms
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1093/annonc/mdz230
ER  -